PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $51,245,000 | -38.3% | 1,148,723 | -33.6% | 0.86% | -27.4% |
| Q4 2019 | $83,053,000 | +25.4% | 1,729,200 | -11.7% | 1.19% | -5.6% |
| Q3 2019 | $66,250,000 | -29.5% | 1,958,900 | -6.3% | 1.26% | -13.7% |
| Q2 2019 | $94,037,000 | +64.4% | 2,089,700 | +37.5% | 1.46% | +64.3% |
| Q1 2019 | $57,202,000 | +9.7% | 1,519,700 | 0.0% | 0.89% | -8.1% |
| Q4 2018 | $52,156,000 | -13.0% | 1,519,700 | +19.2% | 0.96% | +33.5% |
| Q3 2018 | $59,925,000 | +2587.2% | 1,275,000 | +523.8% | 0.72% | +2478.6% |
| Q4 2016 | $2,230,000 | -7.4% | 204,400 | +308.8% | 0.03% | +55.6% |
| Q2 2015 | $2,407,000 | -48.3% | 50,000 | -71.9% | 0.02% | -67.3% |
| Q2 2014 | $4,656,000 | -78.5% | 178,100 | -78.5% | 0.06% | -79.4% |
| Q1 2014 | $21,699,000 | – | 830,100 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |